293 related articles for article (PubMed ID: 32776055)
1. Cytotoxic and antitumor peptides as novel chemotherapeutics.
Luan X; Wu Y; Shen YW; Zhang H; Zhou YD; Chen HZ; Nagle DG; Zhang WD
Nat Prod Rep; 2021 Jan; 38(1):7-17. PubMed ID: 32776055
[TBL] [Abstract][Full Text] [Related]
2. Natural sesquiterpenoids as cytotoxic anticancer agents.
Chen QF; Liu ZP; Wang FP
Mini Rev Med Chem; 2011 Nov; 11(13):1153-64. PubMed ID: 22353224
[TBL] [Abstract][Full Text] [Related]
3. Research Progress in Reversal of Tumor Multi-drug Resistance via Natural Products.
Guo Q; Cao H; Qi X; Li H; Ye P; Wang Z; Wang D; Sun M
Anticancer Agents Med Chem; 2017 Nov; 17(11):1466-1476. PubMed ID: 29034843
[TBL] [Abstract][Full Text] [Related]
4. Anticancer fungal natural products: Mechanisms of action and biosynthesis.
Yuan S; Gopal JV; Ren S; Chen L; Liu L; Gao Z
Eur J Med Chem; 2020 Sep; 202():112502. PubMed ID: 32652407
[TBL] [Abstract][Full Text] [Related]
5. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
Rege K; Patel SJ; Megeed Z; Yarmush ML
Cancer Res; 2007 Jul; 67(13):6368-75. PubMed ID: 17616696
[TBL] [Abstract][Full Text] [Related]
6. From a pro-apoptotic peptide to a lytic peptide: One single residue mutation.
Zhou XR; Zhang Q; Tian XB; Cao YM; Liu ZQ; Fan R; Ding XF; Zhu Z; Chen L; Luo SZ
Biochim Biophys Acta; 2016 Aug; 1858(8):1914-25. PubMed ID: 27207743
[TBL] [Abstract][Full Text] [Related]
7. [Antibody-drug conjugates: design and clinical progress].
Wang YJ; Cao X; Liu XY; Lu XL; Li YY; Jiao BH
Yao Xue Xue Bao; 2016 Aug; 51(8):1209-16. PubMed ID: 29897715
[TBL] [Abstract][Full Text] [Related]
8. [Design of next generation antibody drug conjugates].
Zhu GD; Fu YX
Yao Xue Xue Bao; 2013 Jul; 48(7):1053-70. PubMed ID: 24133971
[TBL] [Abstract][Full Text] [Related]
9. Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue.
Yasunaga M; Manabe S; Tarin D; Matsumura Y
Bioconjug Chem; 2011 Sep; 22(9):1776-83. PubMed ID: 21749132
[TBL] [Abstract][Full Text] [Related]
10. Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.
AlDeghaither D; Smaglo BG; Weiner LM
J Clin Pharmacol; 2015 Mar; 55 Suppl 3(0 3):S4-20. PubMed ID: 25707963
[TBL] [Abstract][Full Text] [Related]
11. Marine Natural Products as Models to Circumvent Multidrug Resistance.
Long S; Sousa E; Kijjoa A; Pinto MM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
[TBL] [Abstract][Full Text] [Related]
12. A personal perspective of the development and validation of a phase-specific antibody-drug conjugate cytotoxicity potency assay.
Wilson R
Bioanalysis; 2013 May; 5(9):1083-97. PubMed ID: 23641698
[TBL] [Abstract][Full Text] [Related]
13. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
14. Natural products with antitumor activity from endophytic fungi.
Wang LW; Zhang YL; Lin FC; Hu YZ; Zhang CL
Mini Rev Med Chem; 2011 Oct; 11(12):1056-74. PubMed ID: 21861806
[TBL] [Abstract][Full Text] [Related]
15. Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma.
Wu Y; Lu D; Jiang Y; Jin J; Liu S; Chen L; Zhang H; Zhou Y; Chen H; Nagle DG; Luan X; Zhang W
J Med Chem; 2021 May; 64(9):5802-5815. PubMed ID: 33844923
[TBL] [Abstract][Full Text] [Related]
16. Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.
Wennier ST; Liu J; McFadden G
Curr Pharm Biotechnol; 2012 Jul; 13(9):1817-33. PubMed ID: 21740354
[TBL] [Abstract][Full Text] [Related]
17. Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature.
Negi B; Kumar D; Rawat DS
Curr Protein Pept Sci; 2017; 18(9):885-904. PubMed ID: 27455970
[TBL] [Abstract][Full Text] [Related]
18. Emerging biopharmaceuticals from bioactive peptides derived from marine organisms.
Anjum K; Abbas SQ; Akhter N; Shagufta BI; Shah SAA; Hassan SSU
Chem Biol Drug Des; 2017 Jul; 90(1):12-30. PubMed ID: 28004491
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Drug Conjugates Containing Payloads from Marine Origin.
Cheng-Sánchez I; Moya-Utrera F; Porras-Alcalá C; López-Romero JM; Sarabia F
Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005497
[TBL] [Abstract][Full Text] [Related]
20. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
Zhang B; Cheng P
Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
